Back to Melanotan-ii research
melanotan-ii melanocortin agonist preclinical animal n preclinical 2026-04-03 PubMed

Time-Restricted Feeding Lowers Blood Pressure Without Weight Loss

Limiting feeding to the active phase reduces blood pressure without the necessity of caloric reduction or fat mass loss.

Background

Time-restricted feeding (TRF) has shown promise in improving metabolic health in both rodents and humans. Previous research demonstrated that TRF can effectively reduce blood pressure (BP) in obese rats. However, it remained unclear whether TRF could lower BP in lean rats and, crucially, if this benefit was independent of caloric restriction or a reduction in fat mass.

Results

The study revealed that TRF during the active phase significantly lowered systolic blood pressure (SBP) by approximately 10 mmHg (p < 0.001) and diastolic blood pressure (DBP) by about 7 mmHg (p < 0.001) when compared to both the ad libitum and inactive-phase TRF groups. Crucially, these significant reductions in blood pressure were observed without any notable changes in body weight, fat mass, or overall caloric intake across the groups. In contrast, TRF during the inactive phase showed no significant effect on blood pressure, highlighting the importance of timing. These findings suggest that the benefits of TRF on cardiovascular health can be independent of weight loss or caloric restriction.

Why It Matters

This research highlights the critical importance of the timing of food intake for maintaining cardiovascular health, suggesting that when one eats can be as significant as what or how much. The findings propose that time-restricted feeding during the active phase could serve as a potential non-pharmacological therapeutic strategy for managing hypertension. Further research, including human clinical trials, is warranted to translate these promising animal study results into clinical practice.


melanotan-ii melanocortin agonist
Source: pubmed:30024775 · Ingested 2026-04-03 · Digest: gemini-2.5-flash